Global Non-opioid Analgesic Patch Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Non-opioid Analgesic Patch Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Non-opioid Analgesic Patch Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Methyl Salicylate Patches
1.2.5 Capsaicin Patches
1.2.6 Ketoprofen Patches
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Non-opioid Analgesic Patch Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Non-opioid Analgesic Patch Market Size (2017-2028)
2.1.1 Global Non-opioid Analgesic Patch Revenue (2017-2028)
2.1.2 Global Non-opioid Analgesic Patch Sales (2017-2028)
2.2 Global Non-opioid Analgesic Patch Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Non-opioid Analgesic Patch Sales by Regions (2017-2022)
2.2.2 Global Non-opioid Analgesic Patch Revenue by Regions (2017-2022)
2.3 Global Non-opioid Analgesic Patch Market Size Forecast by Region
2.3.1 Global Non-opioid Analgesic Patch Sales Forecast by Region (2023-2028)
2.3.2 Global Non-opioid Analgesic Patch Revenue Forecast by Region (2023-2028)
2.4 Global Top Non-opioid Analgesic Patch Regions (Countries) Ranking by Market Size
2.5 Non-opioid Analgesic Patch Market Dynamics
2.5.1 Non-opioid Analgesic Patch Market Trends
2.5.2 Non-opioid Analgesic Patch Market Drivers
2.5.3 Non-opioid Analgesic Patch Market Challenges
2.5.4 Non-opioid Analgesic Patch Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Non-opioid Analgesic Patch Manufacturers by Sales (2017-2022)
3.1.1 Global Non-opioid Analgesic Patch Sales by Manufacturers (2017-2022)
3.1.2 Global Non-opioid Analgesic Patch Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Non-opioid Analgesic Patch Sales in 2021
3.2 Global Top Manufacturers Non-opioid Analgesic Patch by Revenue
3.2.1 Global Non-opioid Analgesic Patch Revenue by Manufacturers (2017-2022)
3.2.2 Top Non-opioid Analgesic Patch Manufacturers Covered: Ranking by Revenue
3.2.3 Global Non-opioid Analgesic Patch Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Non-opioid Analgesic Patch Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-opioid Analgesic Patch as of 2021)
3.4 Global Non-opioid Analgesic Patch Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Non-opioid Analgesic Patch Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Non-opioid Analgesic Patch Market
3.7 Key Manufacturers Non-opioid Analgesic Patch Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Non-opioid Analgesic Patch Market Size by Type
4.1 Global Non-opioid Analgesic Patch Historic Market Review by Type (2017-2022)
4.1.1 Global Non-opioid Analgesic Patch Sales Market Share by Type (2017-2022)
4.1.2 Global Non-opioid Analgesic Patch Revenue Market Share by Type (2017-2022)
4.1.3 Non-opioid Analgesic Patch Price by Type (2017-2022)
4.2 Global Non-opioid Analgesic Patch Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Non-opioid Analgesic Patch Sales Forecast by Type (2023-2028)
4.2.2 Global Non-opioid Analgesic Patch Revenue Forecast by Type (2023-2028)
4.2.3 Non-opioid Analgesic Patch Price Forecast by Type (2023-2028)
5 Global Non-opioid Analgesic Patch Market Size by Application
5.1 Global Non-opioid Analgesic Patch Historic Market Review by Application (2017-2022)
5.1.1 Global Non-opioid Analgesic Patch Sales Market Share by Application (2017-2022)
5.1.2 Global Non-opioid Analgesic Patch Revenue Market Share by Application (2017-2022)
5.1.3 Non-opioid Analgesic Patch Price by Application (2017-2022)
5.2 Global Non-opioid Analgesic Patch Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Non-opioid Analgesic Patch Sales Forecast by Application (2023-2028)
5.2.2 Global Non-opioid Analgesic Patch Revenue Forecast by Application (2023-2028)
5.2.3 Non-opioid Analgesic Patch Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non-opioid Analgesic Patch Sales Breakdown by Company
6.1.1 North America Non-opioid Analgesic Patch Sales by Company (2017-2022)
6.1.2 North America Non-opioid Analgesic Patch Revenue by Company (2017-2022)
6.2 North America Non-opioid Analgesic Patch Market Size by Type
6.2.1 North America Non-opioid Analgesic Patch Sales by Type (2017-2028)
6.2.2 North America Non-opioid Analgesic Patch Revenue by Type (2017-2028)
6.3 North America Non-opioid Analgesic Patch Market Size by Application
6.3.1 North America Non-opioid Analgesic Patch Sales by Application (2017-2028)
6.3.2 North America Non-opioid Analgesic Patch Revenue by Application (2017-2028)
6.4 North America Non-opioid Analgesic Patch Market Size by Country
6.4.1 North America Non-opioid Analgesic Patch Sales by Country (2017-2028)
6.4.2 North America Non-opioid Analgesic Patch Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Non-opioid Analgesic Patch Sales Breakdown by Company
7.1.1 Europe Non-opioid Analgesic Patch Sales by Company (2017-2022)
7.1.2 Europe Non-opioid Analgesic Patch Revenue by Company (2017-2022)
7.2 Europe Non-opioid Analgesic Patch Market Size by Type
7.2.1 Europe Non-opioid Analgesic Patch Sales by Type (2017-2028)
7.2.2 Europe Non-opioid Analgesic Patch Revenue by Type (2017-2028)
7.3 Europe Non-opioid Analgesic Patch Market Size by Application
7.3.1 Europe Non-opioid Analgesic Patch Sales by Application (2017-2028)
7.3.2 Europe Non-opioid Analgesic Patch Revenue by Application (2017-2028)
7.4 Europe Non-opioid Analgesic Patch Market Size by Country
7.4.1 Europe Non-opioid Analgesic Patch Sales by Country (2017-2028)
7.4.2 Europe Non-opioid Analgesic Patch Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-opioid Analgesic Patch Sales Breakdown by Company
8.1.1 Asia Pacific Non-opioid Analgesic Patch Sales by Company (2017-2022)
8.1.2 Asia Pacific Non-opioid Analgesic Patch Revenue by Company (2017-2022)
8.2 Asia Pacific Non-opioid Analgesic Patch Market Size by Type
8.2.1 Asia Pacific Non-opioid Analgesic Patch Sales by Type (2017-2028)
8.2.2 Asia Pacific Non-opioid Analgesic Patch Revenue by Type (2017-2028)
8.3 Asia Pacific Non-opioid Analgesic Patch Market Size by Application
8.3.1 Asia Pacific Non-opioid Analgesic Patch Sales by Application (2017-2028)
8.3.2 Asia Pacific Non-opioid Analgesic Patch Revenue by Application (2017-2028)
8.4 Asia Pacific Non-opioid Analgesic Patch Market Size by Region
8.4.1 Asia Pacific Non-opioid Analgesic Patch Sales by Region
8.4.2 Asia Pacific Non-opioid Analgesic Patch Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Non-opioid Analgesic Patch Sales Breakdown by Company
9.1.1 Latin America Non-opioid Analgesic Patch Sales by Company (2017-2022)
9.1.2 Latin America Non-opioid Analgesic Patch Revenue by Company (2017-2022)
9.2 Latin America Non-opioid Analgesic Patch Market Size by Type
9.2.1 Latin America Non-opioid Analgesic Patch Sales by Type (2017-2028)
9.2.2 Latin America Non-opioid Analgesic Patch Revenue by Type (2017-2028)
9.3 Latin America Non-opioid Analgesic Patch Market Size by Application
9.3.1 Latin America Non-opioid Analgesic Patch Sales by Application (2017-2028)
9.3.2 Latin America Non-opioid Analgesic Patch Revenue by Application (2017-2028)
9.4 Latin America Non-opioid Analgesic Patch Market Size by Country
9.4.1 Latin America Non-opioid Analgesic Patch Sales by Country (2017-2028)
9.4.2 Latin America Non-opioid Analgesic Patch Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-opioid Analgesic Patch Sales Breakdown by Company
10.1.1 Middle East and Africa Non-opioid Analgesic Patch Sales by Company (2017-2022)
10.1.2 Middle East and Africa Non-opioid Analgesic Patch Revenue by Company (2017-2022)
10.2 Middle East and Africa Non-opioid Analgesic Patch Market Size by Type
10.2.1 Middle East and Africa Non-opioid Analgesic Patch Sales by Type (2017-2028)
10.2.2 Middle East and Africa Non-opioid Analgesic Patch Revenue by Type (2017-2028)
10.3 Middle East and Africa Non-opioid Analgesic Patch Market Size by Application
10.3.1 Middle East and Africa Non-opioid Analgesic Patch Sales by Application (2017-2028)
10.3.2 Middle East and Africa Non-opioid Analgesic Patch Revenue by Application (2017-2028)
10.4 Middle East and Africa Non-opioid Analgesic Patch Market Size by Country
10.4.1 Middle East and Africa Non-opioid Analgesic Patch Sales by Country (2017-2028)
10.4.2 Middle East and Africa Non-opioid Analgesic Patch Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Corporation Information
11.1.2 GlaxoSmithKline Plc Overview
11.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Plc Non-opioid Analgesic Patch Products and Services
11.1.5 GlaxoSmithKline Plc Non-opioid Analgesic Patch SWOT Analysis
11.1.6 GlaxoSmithKline Plc Recent Developments
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Corporation Information
11.2.2 Pfizer, Inc. Overview
11.2.3 Pfizer, Inc. Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Pfizer, Inc. Non-opioid Analgesic Patch Products and Services
11.2.5 Pfizer, Inc. Non-opioid Analgesic Patch SWOT Analysis
11.2.6 Pfizer, Inc. Recent Developments
11.3 Teikoku Seiyaku Co., Ltd.
11.3.1 Teikoku Seiyaku Co., Ltd. Corporation Information
11.3.2 Teikoku Seiyaku Co., Ltd. Overview
11.3.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Products and Services
11.3.5 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch SWOT Analysis
11.3.6 Teikoku Seiyaku Co., Ltd. Recent Developments
11.4 Mylan N.V.
11.4.1 Mylan N.V. Corporation Information
11.4.2 Mylan N.V. Overview
11.4.3 Mylan N.V. Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Mylan N.V. Non-opioid Analgesic Patch Products and Services
11.4.5 Mylan N.V. Non-opioid Analgesic Patch SWOT Analysis
11.4.6 Mylan N.V. Recent Developments
11.5 Hisamitsu Pharmaceutical Co.,Inc
11.5.1 Hisamitsu Pharmaceutical Co.,Inc Corporation Information
11.5.2 Hisamitsu Pharmaceutical Co.,Inc Overview
11.5.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Products and Services
11.5.5 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch SWOT Analysis
11.5.6 Hisamitsu Pharmaceutical Co.,Inc Recent Developments
11.6 Acorda Therapeutics, Inc
11.6.1 Acorda Therapeutics, Inc Corporation Information
11.6.2 Acorda Therapeutics, Inc Overview
11.6.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Products and Services
11.6.5 Acorda Therapeutics, Inc Non-opioid Analgesic Patch SWOT Analysis
11.6.6 Acorda Therapeutics, Inc Recent Developments
11.7 Endo International plc
11.7.1 Endo International plc Corporation Information
11.7.2 Endo International plc Overview
11.7.3 Endo International plc Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Endo International plc Non-opioid Analgesic Patch Products and Services
11.7.5 Endo International plc Non-opioid Analgesic Patch SWOT Analysis
11.7.6 Endo International plc Recent Developments
11.8 Allergan
11.8.1 Allergan Corporation Information
11.8.2 Allergan Overview
11.8.3 Allergan Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Allergan Non-opioid Analgesic Patch Products and Services
11.8.5 Allergan Non-opioid Analgesic Patch SWOT Analysis
11.8.6 Allergan Recent Developments
11.9 Teh Seng Pharmaceutical Mfg
11.9.1 Teh Seng Pharmaceutical Mfg Corporation Information
11.9.2 Teh Seng Pharmaceutical Mfg Overview
11.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Products and Services
11.9.5 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch SWOT Analysis
11.9.6 Teh Seng Pharmaceutical Mfg Recent Developments
11.10 IBSA Institut Biochimque SA
11.10.1 IBSA Institut Biochimque SA Corporation Information
11.10.2 IBSA Institut Biochimque SA Overview
11.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Products and Services
11.10.5 IBSA Institut Biochimque SA Non-opioid Analgesic Patch SWOT Analysis
11.10.6 IBSA Institut Biochimque SA Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Non-opioid Analgesic Patch Value Chain Analysis
12.2 Non-opioid Analgesic Patch Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-opioid Analgesic Patch Production Mode & Process
12.4 Non-opioid Analgesic Patch Sales and Marketing
12.4.1 Non-opioid Analgesic Patch Sales Channels
12.4.2 Non-opioid Analgesic Patch Distributors
12.5 Non-opioid Analgesic Patch Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Non-opioid Analgesic Patch Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Lidocaine Patches
Table 3. Major Manufacturers of Diclofenac Patches
Table 4. Major Manufacturers of Methyl Salicylate Patches
Table 5. Major Manufacturers of Capsaicin Patches
Table 6. Major Manufacturers of Ketoprofen Patches
Table 7. Major Manufacturers of Others
Table 8. Global Non-opioid Analgesic Patch Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Non-opioid Analgesic Patch Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Non-opioid Analgesic Patch Sales by Region (2017-2022) & (K Units)
Table 11. Global Non-opioid Analgesic Patch Sales Market Share by Region (2017-2022)
Table 12. Global Non-opioid Analgesic Patch Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Non-opioid Analgesic Patch Revenue Market Share by Region (2017-2022)
Table 14. Global Non-opioid Analgesic Patch Sales Forecast by Region (2023-2028) & (K Units)
Table 15. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Region (2023-2028)
Table 16. Global Non-opioid Analgesic Patch Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 17. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Region (2023-2028)
Table 18. Top Non-opioid Analgesic Patch Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 19. Non-opioid Analgesic Patch Market Trends
Table 20. Non-opioid Analgesic Patch Market Drivers
Table 21. Non-opioid Analgesic Patch Market Challenges
Table 22. Non-opioid Analgesic Patch Market Restraints
Table 23. Global Non-opioid Analgesic Patch Sales by Manufacturers (2017-2022) & (K Units)
Table 24. Global Non-opioid Analgesic Patch Sales Share by Manufacturers (2017-2022)
Table 25. Global Non-opioid Analgesic Patch Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 26. Ranking of Global Top Non-opioid Analgesic Patch Manufacturers by Revenue (US$ Million) in 2021
Table 27. Non-opioid Analgesic Patch Revenue Share by Manufacturers (2017-2022)
Table 28. Global Non-opioid Analgesic Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-opioid Analgesic Patch as of 2021)
Table 30. Key Manufacturers Non-opioid Analgesic Patch Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 31. Key Manufacturers Non-opioid Analgesic Patch Plants/Factories Distribution
Table 32. Key Manufacturers Non-opioid Analgesic Patch Area Served
Table 33. Date of Key Manufacturers Enter into Non-opioid Analgesic Patch Market
Table 34. Key Manufacturers Non-opioid Analgesic Patch Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Non-opioid Analgesic Patch Sales (K Units) by Type (2017-2022)
Table 37. Global Non-opioid Analgesic Patch Sales Share by Type (2017-2022)
Table 38. Global Non-opioid Analgesic Patch Revenue (US$ Million) Market Share by Type (2017-2022)
Table 39. Global Non-opioid Analgesic Patch Price (K Units) by Type (2017-2022)
Table 40. Global Non-opioid Analgesic Patch Sales (K Units) by Type (2023-2028)
Table 41. Global Non-opioid Analgesic Patch Sales Share by Type (2023-2028)
Table 42. Global Non-opioid Analgesic Patch Revenue (US$ Million) Market Share by Type (2023-2028)
Table 43. Global Non-opioid Analgesic Patch Revenue Share by Type (2023-2028)
Table 44. Global Non-opioid Analgesic Patch Price (K Units) by Type (2023-2028)
Table 45. Global Non-opioid Analgesic Patch Sales (K Units) by Application (2017-2022)
Table 46. Global Non-opioid Analgesic Patch Sales Share by Application (2017-2022)
Table 47. Global Non-opioid Analgesic Patch Revenue (US$ Million) Market Share by Application (2017-2022)
Table 48. Global Non-opioid Analgesic Patch Price (K Units) by Application (2017-2022)
Table 49. Global Non-opioid Analgesic Patch Sales (K Units) by Application (2023-2028)
Table 50. Global Non-opioid Analgesic Patch Sales Share by Application (2023-2028)
Table 51. Global Non-opioid Analgesic Patch Revenue (US$ Million) Market Share by Application (2023-2028)
Table 52. Global Non-opioid Analgesic Patch Revenue Share by Application (2023-2028)
Table 53. Global Non-opioid Analgesic Patch Price (K Units) by Application (2023-2028)
Table 54. North America Non-opioid Analgesic Patch Sales by Company (2017-2022) & (K Units)
Table 55. North America Non-opioid Analgesic Patch Sales Market Share by Company (2017-2022)
Table 56. North America Non-opioid Analgesic Patch Revenue by Company (2017-2022) & (US$ Million)
Table 57. North America Non-opioid Analgesic Patch Revenue Market Share by Company (2017-2022)
Table 58. North America Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 59. North America Non-opioid Analgesic Patch Sales by Type (2023-2028) & (K Units)
Table 60. North America Non-opioid Analgesic Patch Revenue by Type (2017-2022) & (US$ Million)
Table 61. North America Non-opioid Analgesic Patch Revenue by Type (2023-2028) & (US$ Million)
Table 62. North America Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 63. North America Non-opioid Analgesic Patch Sales by Application (2023-2028) & (K Units)
Table 64. North America Non-opioid Analgesic Patch Revenue by Application (2017-2022) & (US$ Million)
Table 65. North America Non-opioid Analgesic Patch Revenue by Application (2023-2028) & (US$ Million)
Table 66. North America Non-opioid Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 67. North America Non-opioid Analgesic Patch Sales by Country (2023-2028) & (K Units)
Table 68. North America Non-opioid Analgesic Patch Revenue by Country (2017-2022) & (US$ Million)
Table 69. North America Non-opioid Analgesic Patch Revenue by Country (2023-2028) & (US$ Million)
Table 70. Europe Non-opioid Analgesic Patch Sales by Company (2017-2022) & (K Units)
Table 71. Europe Non-opioid Analgesic Patch Sales Market Share by Company (2017-2022)
Table 72. Europe Non-opioid Analgesic Patch Revenue by Company (2017-2022) & (US$ Million)
Table 73. Europe Non-opioid Analgesic Patch Revenue Market Share by Company (2017-2022)
Table 74. Europe Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 75. Europe Non-opioid Analgesic Patch Sales by Type (2023-2028) & (K Units)
Table 76. Europe Non-opioid Analgesic Patch Revenue by Type (2017-2022) & (US$ Million)
Table 77. Europe Non-opioid Analgesic Patch Revenue by Type (2023-2028) & (US$ Million)
Table 78. Europe Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 79. Europe Non-opioid Analgesic Patch Sales by Application (2023-2028) & (K Units)
Table 80. Europe Non-opioid Analgesic Patch Revenue by Application (2017-2022) & (US$ Million)
Table 81. Europe Non-opioid Analgesic Patch Revenue by Application (2023-2028) & (US$ Million)
Table 82. Europe Non-opioid Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 83. Europe Non-opioid Analgesic Patch Sales by Country (2023-2028) & (K Units)
Table 84. Europe Non-opioid Analgesic Patch Revenue by Country (2017-2022) & (US$ Million)
Table 85. Europe Non-opioid Analgesic Patch Revenue by Country (2023-2028) & (US$ Million)
Table 86. Asia Pacific Non-opioid Analgesic Patch Sales by Company (2017-2022) & (K Units)
Table 87. Asia Pacific Non-opioid Analgesic Patch Sales Market Share by Company (2017-2022)
Table 88. Asia Pacific Non-opioid Analgesic Patch Revenue by Company (2017-2022) & (US$ Million)
Table 89. Asia Pacific Non-opioid Analgesic Patch Revenue Market Share by Company (2017-2022)
Table 90. Asia Pacific Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 91. Asia Pacific Non-opioid Analgesic Patch Sales by Type (2023-2028) & (K Units)
Table 92. Asia Pacific Non-opioid Analgesic Patch Revenue by Type (2017-2022) & (US$ Million)
Table 93. Asia Pacific Non-opioid Analgesic Patch Revenue by Type (2023-2028) & (US$ Million)
Table 94. Asia Pacific Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 95. Asia Pacific Non-opioid Analgesic Patch Sales by Application (2023-2028) & (K Units)
Table 96. Asia Pacific Non-opioid Analgesic Patch Revenue by Application (2017-2022) & (US$ Million)
Table 97. Asia Pacific Non-opioid Analgesic Patch Revenue by Application (2023-2028) & (US$ Million)
Table 98. Asia Pacific Non-opioid Analgesic Patch Sales by Region (2017-2022) & (K Units)
Table 99. Asia Pacific Non-opioid Analgesic Patch Sales by Region (2023-2028) & (K Units)
Table 100. Asia Pacific Non-opioid Analgesic Patch Revenue by Region (2017-2022) & (US$ Million)
Table 101. Asia Pacific Non-opioid Analgesic Patch Revenue by Region (2023-2028) & (US$ Million)
Table 102. Latin America Non-opioid Analgesic Patch Sales by Company (2017-2022) & (K Units)
Table 103. Latin America Non-opioid Analgesic Patch Sales Market Share by Company (2017-2022)
Table 104. Latin America Non-opioid Analgesic Patch Revenue by Company (2017-2022) & (US$ Million)
Table 105. Latin America Non-opioid Analgesic Patch Revenue Market Share by Company (2017-2022)
Table 106. Latin America Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 107. Latin America Non-opioid Analgesic Patch Sales by Type (2023-2028) & (K Units)
Table 108. Latin America Non-opioid Analgesic Patch Revenue by Type (2017-2022) & (US$ Million)
Table 109. Latin America Non-opioid Analgesic Patch Revenue by Type (2023-2028) & (US$ Million)
Table 110. Latin America Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 111. Latin America Non-opioid Analgesic Patch Sales by Application (2023-2028) & (K Units)
Table 112. Latin America Non-opioid Analgesic Patch Revenue by Application (2017-2022) & (US$ Million)
Table 113. Latin America Non-opioid Analgesic Patch Revenue by Application (2023-2028) & (US$ Million)
Table 114. Latin America Non-opioid Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 115. Latin America Non-opioid Analgesic Patch Sales by Country (2023-2028) & (K Units)
Table 116. Latin America Non-opioid Analgesic Patch Revenue by Country (2017-2022) & (US$ Million)
Table 117. Latin America Non-opioid Analgesic Patch Revenue by Country (2023-2028) & (US$ Million)
Table 118. Middle East and Africa Non-opioid Analgesic Patch Sales by Company (2017-2022) & (K Units)
Table 119. Middle East and Africa Non-opioid Analgesic Patch Sales Market Share by Company (2017-2022)
Table 120. Middle East and Africa Non-opioid Analgesic Patch Revenue by Company (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Non-opioid Analgesic Patch Revenue Market Share by Company (2017-2022)
Table 122. Middle East and Africa Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 123. Middle East and Africa Non-opioid Analgesic Patch Sales by Type (2023-2028) & (K Units)
Table 124. Middle East and Africa Non-opioid Analgesic Patch Revenue by Type (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Non-opioid Analgesic Patch Revenue by Type (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 127. Middle East and Africa Non-opioid Analgesic Patch Sales by Application (2023-2028) & (K Units)
Table 128. Middle East and Africa Non-opioid Analgesic Patch Revenue by Application (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Non-opioid Analgesic Patch Revenue by Application (2023-2028) & (US$ Million)
Table 130. Middle East and Africa Non-opioid Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 131. Middle East and Africa Non-opioid Analgesic Patch Sales by Country (2023-2028) & (K Units)
Table 132. Middle East and Africa Non-opioid Analgesic Patch Revenue by Country (2017-2022) & (US$ Million)
Table 133. Middle East and Africa Non-opioid Analgesic Patch Revenue by Country (2023-2028) & (US$ Million)
Table 134. GlaxoSmithKline Plc Corporation Information
Table 135. GlaxoSmithKline Plc Description and Overview
Table 136. GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 137. GlaxoSmithKline Plc Non-opioid Analgesic Patch Product and Services
Table 138. GlaxoSmithKline Plc Non-opioid Analgesic Patch SWOT Analysis
Table 139. GlaxoSmithKline Plc Recent Developments
Table 140. Pfizer, Inc. Corporation Information
Table 141. Pfizer, Inc. Description and Overview
Table 142. Pfizer, Inc. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 143. Pfizer, Inc. Non-opioid Analgesic Patch Product and Services
Table 144. Pfizer, Inc. Non-opioid Analgesic Patch SWOT Analysis
Table 145. Pfizer, Inc. Recent Developments
Table 146. Teikoku Seiyaku Co., Ltd. Corporation Information
Table 147. Teikoku Seiyaku Co., Ltd. Description and Overview
Table 148. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 149. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product and Services
Table 150. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch SWOT Analysis
Table 151. Teikoku Seiyaku Co., Ltd. Recent Developments
Table 152. Mylan N.V. Corporation Information
Table 153. Mylan N.V. Description and Overview
Table 154. Mylan N.V. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 155. Mylan N.V. Non-opioid Analgesic Patch Product and Services
Table 156. Mylan N.V. Non-opioid Analgesic Patch SWOT Analysis
Table 157. Mylan N.V. Recent Developments
Table 158. Hisamitsu Pharmaceutical Co.,Inc Corporation Information
Table 159. Hisamitsu Pharmaceutical Co.,Inc Description and Overview
Table 160. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 161. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product and Services
Table 162. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch SWOT Analysis
Table 163. Hisamitsu Pharmaceutical Co.,Inc Recent Developments
Table 164. Acorda Therapeutics, Inc Corporation Information
Table 165. Acorda Therapeutics, Inc Description and Overview
Table 166. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 167. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product and Services
Table 168. Acorda Therapeutics, Inc Non-opioid Analgesic Patch SWOT Analysis
Table 169. Acorda Therapeutics, Inc Recent Developments
Table 170. Endo International plc Corporation Information
Table 171. Endo International plc Description and Overview
Table 172. Endo International plc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 173. Endo International plc Non-opioid Analgesic Patch Product and Services
Table 174. Endo International plc Non-opioid Analgesic Patch SWOT Analysis
Table 175. Endo International plc Recent Developments
Table 176. Allergan Corporation Information
Table 177. Allergan Description and Overview
Table 178. Allergan Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 179. Allergan Non-opioid Analgesic Patch Product and Services
Table 180. Allergan Non

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs